Drugs / TIL-TC150
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02983695 | Feb 2017 → Aug 2018 | epilepsy | The Hospital for Sick Children | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TIL-TC150 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02983695 ↗ |
| Known as | TIL-TC150 Oil | “TIL-TC150 Oil is the study product” NCT02983695 ↗ |
| Route | Oral | “formulated into an oral liquid drug product.” NCT02983695 ↗ |